During the past decade, Clinical Center of Serbia, Clinic of Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Center of Serbia, Clinic of Hematology" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Amgen" with 1 trials sponsored, "CTI BioPharma" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Center of Serbia, Clinic of Hematology" #1 collaborator was "Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Center of Serbia, Clinic of Hematology" are "Multiple Myeloma" (2 trials), "B-Cell Chronic Lymphocytic Leukemia (B-CLL)" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Disease, Hodgkin" (1 trials). Many other conditions were trialed in "Clinical Center of Serbia, Clinic of Hematology" in a lesser frequency.

Most popular intervention types in "Clinical Center of Serbia, Clinic of Hematology" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Dexamethasone" (3 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Center of Serbia, Clinic of Hematology" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Center of Serbia, Clinic of Hematology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clinical Center of Serbia, Clinic of Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Center of Serbia, Clinic of Hematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".